SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
BMS, Merck and Pfizer Join List of Companies Pausing Some Clinical Trials During Pandemic
As COVID-19 continues to expand across the globe, more pharmaceutical companies are hitting the brakes on clinical trials as part of an effort to ease the burden on doctors and facilities needed to treat patients combating the disease.
March 27, 2020
 · 
3 min read
 · 
Alex Keown
Drug Development
Biopharma Industry News for March 27: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
March 27, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 26: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
March 26, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 25: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
March 25, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 24: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
March 24, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Eli Lilly Among Companies Pausing Some Clinical Trials Due to COVID-19 Pandemic
This morning, the Indianapolis-based company said it will delay most new study starts and pause enrollment in most ongoing studies in light of the COVID-19 pandemic.
March 23, 2020
 · 
3 min read
 · 
Alex Keown
Drug Development
Biopharma Industry News for March 23: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
March 23, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
BioCapital
Clinical Catch-Up: March 16-20
Here’s a look at some of last week’s clinical trial news.
March 20, 2020
 · 
7 min read
 · 
Mark Terry
Drug Development
Biopharma Industry News for March 20: Update on the Novel Coronavirus
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
March 20, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 19: Update on the Novel Coronavirus
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
March 19, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1)
February 26, 2026
 · 
5 min read
Press Releases
Aramis Biotechnologies announces the achievement of an important milestone with the start of a Phase 1/2 clinical trial of its vaccine in development against seasonal influenza in 728 participants
February 26, 2026
 · 
2 min read
Press Releases
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
February 26, 2026
 · 
7 min read
Press Releases
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
February 26, 2026
 · 
3 min read
Press Releases
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
February 26, 2026
 · 
5 min read
Press Releases
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
February 26, 2026
 · 
7 min read
Press Releases
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds
February 26, 2026
 · 
2 min read
Press Releases
Kivu Bioscience Presents KIVU-305 Preclinical Data at World ADC London 2026 and Advances into Phase 1 Clinical Trial
February 26, 2026
 · 
3 min read
Press Releases
Mahzi Therapeutics Announces First Patient Dosed in Phase 1/2 UNITE Study of MZ-1866 for Pitt Hopkins Syndrome
February 26, 2026
 · 
4 min read
Press Releases
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
February 25, 2026
 · 
11 min read
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 25, 2026
 · 
5 min read
Press Releases
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
February 25, 2026
 · 
8 min read
Press Releases
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
February 25, 2026
 · 
7 min read
Press Releases
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
February 25, 2026
 · 
6 min read
Press Releases
Vico Therapeutics Announces Patient Dosing in Twice-Annual Regimen of VO659 in Phase 1/2 Trial in Huntington’s Disease, Spinocerebellar Ataxia Type 3 and Type 1
February 24, 2026
 · 
3 min read
Press Releases
Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
February 24, 2026
 · 
4 min read
Press Releases
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
February 24, 2026
 · 
10 min read
Press Releases
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
February 24, 2026
 · 
6 min read
Load More